Calendar Celyad Oncology SA

Equities

CYAD

BE0974260896

Real-time Euronext Bruxelles 04:05:29 2024-04-24 am EDT 5-day change 1st Jan Change
0.3145 EUR -4.70% Intraday chart for Celyad Oncology SA -5.98% -19.36%

Chart calendar Celyad Oncology SA

0808dc52c6676d61386de5b5.F6tEo5OzuIVwSpF-Lq4ubW2sMcAUCTD8zc2EldObWrM.cNE3jtnD08sCJ-cwH8FFDjnja5csPAeGg4a94qnLLoFv6Q_2osXf8yQeqQ~da297b57a068ddd9e2ee8bac3e29abe5

Upcoming events on Celyad Oncology SA

2024-05-01 Q1 2024 Earnings Release (Projected)
2024-05-05 Annual General Meeting
2024-09-20 01:00 am Q2 2024 Earnings Release
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-19 Q4 2024 Earnings Release (Projected)
2025-08-05 Q2 2025 Earnings Release (Projected)

Past events on Celyad Oncology SA

2024-04-04 01:00 am Q4 2023 Earnings Release
2024-02-26 CAR-TCR Europe summit
2023-11-14 08:00 am Extraordinary Shareholders Meeting
2023-11-09 01:00 am Q3 2023 Earnings Release
2023-10-10 BioJapan Conference
2023-09-11 International Conference on Lymphocyte Engineering
2023-09-05 07:00 am Q2 2023 Earnings Call
2023-09-04 01:00 am Q2 2023 Earnings Release
2023-06-19 Immuno-Oncology Summit
2023-06-04 BIO International Convention
2023-05-05 01:00 am Q1 2023 Earnings Release
2023-05-04 Annual General Meeting
2023-03-24 08:00 am Q4 2022 Earnings Call
2023-03-23 05:01 pm Q4 2022 Earnings Release
2023-02-03 01:00 am FY 2022 Sales and Revenue Release
2022-11-10 01:01 am Q3 2022 Earnings Release
2022-08-05 08:00 am Interim 2022 Earnings Call
2022-08-04 Interim 2022 Earnings Release
2022-05-24 07:00 am H.C. Wainwright Global Life Sciences Investment Conference
2022-05-05 04:01 pm Q1 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021
Net sales
Million EUR
Released
Forecast
Spread
0,01
0,00
-
0,01
0,84
-99.4%
0,00
5,40
-
EBITDA
Million EUR
Released
Forecast
Spread
-27,1
-36,7
26.18%
-15,2
-24,8
38.98%
-24,9
-26,3
5.48%
EBIT
Million EUR
Released
Forecast
Spread
-28,9
-34,1
15.25%
-17,0
-23,7
28.43%
-26,4
-27,2
2.95%
Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-28,6
-34,0
15.83%
-17,2
-32,9
47.73%
-26,5
-28,4
6.64%
Net income
Million EUR
Released
Forecast
Spread
-28,6
-34,0
15.85%
-17,2
-29,1
40.83%
-26,5
-28,4
6.6%
EPS
EUR
Released
Forecast
Spread
-2,29
-1,80
-27.57%
-1,23
-2,01
38.89%
-1,70
-1,28
-32.81%
Announcement Date24/03/2024/03/2124/03/22

Quarterly results

Fiscal PeriodDecember 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2
Net sales
Million EUR
Released
Forecast
Spread
0,01
0,00
-
0,01
1,29
-99.61%
0,00
0,00
-
0,00
0,00
-
0,00
7,20
-
EBIT
Million EUR
Released
Forecast
Spread
-12,9
-17,5
26.11%
-16,6
-16,8
0.98%
-0,43
-16,4
97.36%
-14,9
-15,5
4.26%
-11,5
-11,8
2.66%
Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-12,7
-17,5
27.59%
-16,6
-16,7
0.56%
-0,61
-16,3
96.28%
-14,9
-15,5
4.41%
-11,6
-13,2
12.01%
Net income
Million EUR
Released
Forecast
Spread
-12,7
-17,5
27.63%
-16,6
-16,7
0.54%
-0,61
-16,3
96.28%
-14,9
-15,5
4.41%
-11,7
-13,2
11.94%
Announcement Date24/03/2006/08/2024/03/2104/08/2124/03/22

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CYAD Stock
  4. Calendar Celyad Oncology SA